ConductScience.org, home

Trial · NCT07896226

A Single Dose of Intravenous Penicillin as an Adjunct to Oral Penicillin in the Treatment of Acute Tonsillitis, Peritonsillar Phlegmon, and Peritonsillar Abscess

NCT07896226, Phase 4, Recruiting, Tejs Ehlers Klug

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Single Dose of Intravenous Penicillin as an Adjunct to Oral Penicillin in the Treatment of Acute Tonsillitis, Peritonsillar Phlegmon, and Peritonsillar Abscess. Trials, record NCT07896226. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07896226

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Single Dose of Intravenous Penicillin as an Adjunct to Oral Penicillin in the Treatment of Acute Tonsillitis, Peritonsillar Phlegmon, and Peritonsillar Abscess
NCT number
NCT07896226
Status
Recruiting
Phases
Phase 4
Enrollment
154 participants, estimated
Lead sponsor
Tejs Ehlers Klug
Conditions
Acute Tonsillitis, Peritonsillar Abscess, Peritonsillar Cellulitis
Interventions
Benzylpenicillin, Isotonic NaCl (Placebo)
First posted
2026-10-26
Last updated
2026-11-04

Source ClinicalTrials.gov

Registered outcomes13

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySTAT-10 ScoreDay 2 (the day after enrollment)
Sore Throat Assessment Tool-10 (STAT-10), a disease-specific patient-reported outcome measure. Ten items, each rated from 1 (not at all) to 5 (to a very high degree); total score range 10-50, with higher scores indicating greater symptom burden. Assessed in the acute tonsillitis (AT) and peritonsillar phlegmon (PP) groups.
PrimaryPTAAT-12 ScoreDay 2 (the day after enrollment)
Peritonsillar Abscess Assessment Tool-12 (PTAAT-12), a disease-specific patient-reported outcome measure. Twelve items, each rated from 1 (not at all) to 5 (to a very high degree); total score range 12-60, with higher scores indicating greater symptom burden. Assessed in the peritonsillar abscess (PTA) group.
PrimaryTime to Symptom ResolutionFrom enrollment until reported recovery (daily questionnaire, days 1-7)Time from enrollment to the first day on which the participant reports feeling recovered in the daily electronic questionnaire. All patients (AT, PP, and PTA groups).
SecondaryVAS Pain ScoreDay 2 (the day after enrollment)
Throat pain measured on a Visual Analogue Scale (VAS) from 0 (no pain) to 10 (worst imaginable pain); higher scores indicate more pain (worse outcome). Reported as: (a) average pain during the day, (b) maximum pain during the day, (c) minimum pain during the day, and (d) current pain. All patients (AT, PP, and PTA groups).
SecondaryUse of AnalgesicsDays 1-7 (collectively)Total consumption of the standardized as-needed analgesics (paracetamol and ibuprofen) during days 1-7. All patients (AT, PP, and PTA groups).
SecondaryAccumulated PTAAT-12 ScoreDays 1-7 (collectively)Sum of daily PTAAT-12 scores during days 1-7 (each daily score 12-60; higher scores indicate greater symptom burden). Peritonsillar abscess (PTA) group.
SecondaryAccumulated STAT-10 ScoreDays 1-7 (collectively)Sum of daily STAT-10 scores during days 1-7 (each daily score 10-50; higher scores indicate greater symptom burden). Acute tonsillitis (AT) and peritonsillar phlegmon (PP) groups.
SecondaryComplicationsFrom enrollment to 14 days follow-up
Occurrence of complications within 14 days of inclusion. AT and PP groups: hospital admission, abscess formation, and spread of infection. PTA group: hospital admission, tonsillectomy, and spread of infection.
SecondaryTOI-14 ScoreAt 6 and 12 months follow-up, respectively
Tonsillectomy Outcome Inventory-14 (TOI-14), a patient-reported questionnaire on throat-related symptoms and their consequences during the preceding 6 months. Fourteen items, each rated on a 6-point scale from 'no problem' to 'problem as bad as it can be'; higher scores indicate greater burden. All patients (AT, PP, and PTA groups).
SecondaryTonsillectomyFrom enrollment to 12 months follow-upProportion of patients who have undergone tonsillectomy. All patients (AT, PP, and PTA groups).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers14

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
2327842BACKGROUNDPubMed
10633576BACKGROUNDPubMed
18830726BACKGROUNDPubMed
19842975BACKGROUNDPubMed
24810966BACKGROUNDPubMed
25658551BACKGROUNDPubMed
25658556BACKGROUNDPubMed
25876001BACKGROUNDPubMed
31495371BACKGROUNDPubMed
34934774BACKGROUNDPubMed

1 to 10 of 14

See all 14 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07896226

GET https://conductscience.org/api/trials/v1/NCT07896226/registered